Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Legend Biotech Corporation (DE:9LB)
FRANKFURT:9LB
Holding DE:9LB?
Track your performance easily
See the Price Targets and Ratings of:
9LB Analyst Ratings
Strong Buy
15 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
9LB Stock 12 Month Forecast
Average Price Target
€79.74
▲(143.10% Upside)
| Highest Price Target€90.70 | Average Price Target€79.74 | Lowest Price Target€62.72 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
William Blair
Reiterated
12/10/24
BTIG
Reiterated
12/10/24
H.C. Wainwright
Reiterated
12/10/24
RBC Capital
Reiterated
12/09/24
Morgan Stanley
Reiterated
12/09/24
BMO Capital
Assigned
12/09/24
Cantor Fitzgerald
Reiterated
12/09/24
Truist Financial
Assigned
11/14/24
Barclays
Reiterated
11/13/24
Scotiabank
€73.33
Buy
123.57%
Upside
Reiterated
11/13/24
Legend Biotech (LEGN) Receives a Buy from Scotiabank
Jefferies
€90.7
Buy
176.52%
Upside
Assigned
10/14/24
Buy Rating for Legend Biotech's Carvykti: Anticipated Market Share Growth and Positive Sales Outlook
TD Cowen
€64.65
Buy
97.09%
Upside
Reiterated
10/11/24
TD Cowen reiterates Buy Rating on Legend Biotech Corp. (LEGN)TD Cowen analyst Yaron Werber reiterated a Buy rating and $67.00 price target on Legend Biotech Corp. (NASDAQ: LEGN).
Redburn Atlantic
€82.98
Buy
152.98%
Upside
Initiated
10/08/24
Legend Biotech initiated with a Buy at Redburn AtlanticLegend Biotech initiated with a Buy at Redburn Atlantic
Piper Sandler
€86.84
Buy
164.75%
Upside
Reiterated
09/30/24
Piper Sandler Sticks to Their Buy Rating for Legend Biotech (LEGN)
Best Analysts Covering Legend Biotech
Which Analyst Should I Follow If I Want to Buy DE:9LB and Sell After:
1 Month
xxx
Success Rate
7/12 ratings generated profit
Average Return
+1.57%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 58.33% of your transactions generating a profit, with an average return of +1.57% per trade.
3 Months
xxx
Success Rate
5/12 ratings generated profit
Average Return
+1.41%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 41.67% of your transactions generating a profit, with an average return of +1.41% per trade.
1 Year
Success Rate
6/12 ratings generated profit
Average Return
-7.93%
reiterated a buy rating 3 months ago
Copying Edward Tenthoff's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -7.93% per trade.
2 Years
xxx
Success Rate
12/30 ratings generated profit
Average Return
-2.33%
reiterated a xxx
rating 12 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 40.00% of your transactions generating a profit, with an average return of -2.33% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
9LB Analyst Recommendation Trends
Rating
Aug 24
Sep 24
Oct 24
Nov 24
Dec 24
Strong Buy
15
15
22
27
28
Buy
10
11
7
5
4
Hold
1
2
2
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
26
28
31
34
34
Each month's total comprises the sum of three months' worth of ratings.
9LB Financial Forecast
9LB Stock Forecast FAQ
What is DE:9LB’s average 12-month price target, according to analysts?
Based on analyst ratings, Legend Biotech Corporation’s 12-month average price target is €79.74.
What is DE:9LB’s upside potential, based on the analysts’ average price target?
Legend Biotech Corporation has 143.10% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Legend Biotech Corporation a Buy, Sell or Hold?
Legend Biotech Corporation has a consensus rating of Strong Buy, which is based on 15 buy ratings, 1 hold ratings and 0 sell ratings.
What is Legend Biotech Corporation’s share price target?
The average share price target for Legend Biotech Corporation is €79.74. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €90.70 ,and the lowest forecast is €62.72. The average share price target represents 143.10% Increase from the current price of €32.8.
The highest analyst share price target is €90.70 ,and the lowest forecast is €62.72. The average share price target represents 143.10% Increase from the current price of €32.8.
What do analysts say about Legend Biotech Corporation?
Legend Biotech Corporation’s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Streets Analysts.
How can I buy shares of Legend Biotech Corporation?
To buy shares of DE:9LB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.